CompoAtlas

Flex-OFlex Extra-fort

Natural health product licensed in Canada

Licence holder
Bronchosirum Inc.
NPN or DIN-HM
02238137
Status
Active licence
Licence date
17 December 2007
Revision date
5 August 2025
Form
Crème
Route of administration
Topique, Transdermique
Application type
DIN de transition

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Sorbate de potassium, Huile d'eucalyptus, (p)-hydroxybenzoate de propyle, Distéarate de glycol, propylèneglycol, Acide stéarique, triéthanolamine, Cétostéaryl sulfate de sodium, diazolidinyl urée, Eau, Polysorbate 60, Stéarate de sorbitan, (p)-hydroxybenzoate de méthyle, Gaultheria procumbens

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Crèmeminimum: 3 Tous les jours ; maximum: 4 Tous les jours
Enfantsminimum: 2 years1 Crèmeminimum: 3 Tous les jours ; maximum: 4 Tous les jours

Uses authorised in Canada

Soulage temporairement la douleur et les courbatures des muscles et des articulations.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 02238137

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line